Current clinical practice of subcutaneous implantable cardioverter-defibrillator: Analysis using the JROAD-DPC database
Current evidence describing the characteristics of subcutaneous implantable cardioverter-defibrillator (S-ICD) therapy, its trend, and perioperative outcomes compared with transvenous implantable cardioverter-defibrillator (TV-ICD) based on a real-world, large-scale database is scarce. The purpose o...
Gespeichert in:
Veröffentlicht in: | Heart rhythm 2022-06, Vol.19 (6), p.909-916 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Current evidence describing the characteristics of subcutaneous implantable cardioverter-defibrillator (S-ICD) therapy, its trend, and perioperative outcomes compared with transvenous implantable cardioverter-defibrillator (TV-ICD) based on a real-world, large-scale database is scarce.
The purpose of this study was to identify the characteristics of current S-ICD therapy using a nationwide database.
A retrospective analysis of ICD implantation was performed using a nationwide database obtained between 2016 and 2020. A total of 8690 patients implanted with ICD (median age 65 [52–72] year; 6902 men; 2021 S-ICD recipients) were analyzed.
Younger patients were more prone to have S-ICD (P |
---|---|
ISSN: | 1547-5271 1556-3871 |
DOI: | 10.1016/j.hrthm.2022.02.006 |